- A phase 2 study of cisplatin analog CI-973 in the treatment of patients with refractory, advanced ovarian cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 1996 Academic Article GET IT
A phase II trial of CI-921 in advanced malignancies.
Investigational new drugs.
Times cited: 23